Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001902078 | SCV002129630 | pathogenic | Walker-Warburg congenital muscular dystrophy | 2020-11-21 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the C-terminus of the FKRP protein. Other variant(s) that disrupt this region (p.Gln460*) have been determined to be pathogenic (PMID: 16476814, Invitae). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. This variant has not been reported in the literature in individuals with FKRP-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu446Alafs*17) in the FKRP gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 50 amino acid(s) of the FKRP protein. |
Baylor Genetics | RCV004571446 | SCV005057797 | likely pathogenic | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 | 2023-12-30 | criteria provided, single submitter | clinical testing |